Description

MOXYFINITY-625 Tablets contain a proven combination of Amoxycillin and Potassium Clavulanate, designed to provide enhanced protection against bacterial infections, including those caused by beta-lactamase–producing organisms. Amoxycillin, a broad-spectrum penicillin antibiotic, works by inhibiting bacterial cell wall synthesis, while Clavulanate potassium acts as a beta-lactamase inhibitor, restoring and extending the antibacterial activity of Amoxycillin.

This combination is widely prescribed for infections of the respiratory tract, ear, nose, throat, urinary tract, skin, and soft tissues, as well as dental infections. MOXYFINITY-625 offers reliable bacterial coverage, faster symptom resolution, and improved treatment outcomes when used as directed.

Key Highlights:

• Contains Amoxycillin + Potassium Clavulanate

• Broad-spectrum antibacterial action

• Effective against beta-lactamase–producing bacteria

• Commonly used in respiratory, ENT, UTI, and skin infections

• Helps reduce infection severity and duration

• Enhances treatment efficacy and patient compliance

• To be used under medical supervision

Dosage and duration should be followed strictly as prescribed by the physician to ensure optimal therapeutic results and minimize resistance.

If you want Monopoly PCD Franchise In Panchkula than please contact us.